PRRT2 and neoplasm: The spatiotemporal targeting precision of nanodrugs critically influences their therapeutic index by enhancing tumor-specific cytotoxicity through mechanisms such as receptor-mediated endocytosis (e.g., PKC targeting), while reducing off-target effects [49, 50].